Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Mamas Creations | MAMA | Feb 28, 2025 | 6.12 | +2.60 |
Mammoth Energy Services | TUSK | Feb 28, 2025 | 2.45 | +6.52 |
Manchester United A | MANU | Feb 28, 2025 | 14.66 | -0.54 |
Mangoceuticals | MGRX | Feb 28, 2025 | 4.13 | -1.78 |
Manhattan Associates | MANH | Feb 28, 2025 | 176.88 | +0.96 |
Manhattan Bridge Capital | LOAN | Feb 28, 2025 | 5.58 | -0.53 |
Manitowoc | MTW | Feb 28, 2025 | 10.35 | -0.86 |
Mannatech | MTEX | Feb 28, 2025 | 11.30 | +1.80 |
MannKind | MNKD | Feb 28, 2025 | 5.34 | +2.10 |
ManpowerGroup | MAN | Feb 28, 2025 | 57.63 | +3.22 |
Manulife Financial | MFC | Feb 28, 2025 | 31.16 | +1.27 |
Maplebear | CART | Feb 28, 2025 | 41.09 | +0.87 |
Marathon Digital | MARA | Feb 28, 2025 | 13.92 | +6.02 |
Marathon Petroleum | MPC | Feb 28, 2025 | 150.18 | +1.49 |
Maravai LifeSciences A | MRVI | Feb 28, 2025 | 3.22 | +5.57 |
Marblegate Acquisition A | GATE | Feb 28, 2025 | 11.00 | 0.00 |
Marchex B | MCHX | Feb 28, 2025 | 1.99 | +1.02 |
Marcus | MCS | Feb 28, 2025 | 18.34 | -1.08 |
Marcus & Millichap | MMI | Feb 28, 2025 | 38.48 | -1.23 |
Marex Group | MRX | Feb 28, 2025 | 36.64 | -0.57 |
Marin Software | MRIN | Feb 28, 2025 | 1.69 | -0.59 |
Marine Petroleum Trust U | MARPS | Feb 28, 2025 | 3.90 | -1.52 |
Marine Products | MPX | Feb 28, 2025 | 8.60 | +1.06 |
MarineMax | HZO | Feb 28, 2025 | 25.35 | -0.71 |
Marinus Pharmaceuticals | MRNS | Feb 28, 2025 | 0.55 | 0.00 |
Maris-Tech | MTEK | Feb 28, 2025 | 2.23 | -3.68 |
Markel | MKL | Feb 28, 2025 | 1 933.44 | +1.85 |
Marker Therapeutics | MRKR | Feb 28, 2025 | 1.53 | +0.33 |
Market Vectors Bdc Income ETF | BIZD | Feb 28, 2025 | 17.55 | +1.45 |
Market Vectors Investment Grade | FLTR | Feb 28, 2025 | 25.58 | +0.08 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.